Comment on CMS-2026-1255-0001

Summary: Vizient, Inc., a healthcare performance improvement company, supports the proposed rule to standardize electronic prior authorization (ePA) for drugs and improve transparency. They suggest specific improvements, including more granular reporting of PA metrics, shorter decision timeframes for expedited requests, and more flexible compliance timelines for new interoperability standards.